$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Qidong, China, 1992-2000 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10Total includedDeadAliveComplete FUMedian FU (in months)
No.%No.%No.%
C03-06Oral cavity352262.91337.135100.06.1
C11Nasopharynx16410664.65835.4164100.08.2
C15Oesophagus94287192.5717.5942100.03.6
C16Stomach3254262580.762919.33254100.04.5
C17Small intestine352982.9617.135100.04.3
C18Colon31518458.413141.6315100.07.4
C19-20Rectum101069668.931431.11010100.07.8
C22Liver7090642490.66669.47090100.02.7
C23-24Gall bladder1008787.01313.0100100.02.8
C25Pancreas66159590.06610.0661100.02.8
C30-31Nose/Sinuses453066.71533.345100.014.6
C32Larynx472655.32144.747100.010.7
C33-34Lung3281294089.634110.43281100.03.4
C37-38Other thoracic organs383284.2615.838100.04.9
C40-41Bone14912684.62315.4149100.04.3
C43Melanoma skin362775.0925.036100.09.4
C44Other skin1208974.23125.8120100.07.2
C47+C49Connective tissue322165.61134.432100.09.8
C50Breast65123936.741263.3651100.025.5
C53Cervix1448659.75840.3144100.07.9
C54Corpus uteri692739.14260.969100.021.1
C55Uterus unspecified412561.01639.041100.08.1
C56Ovary1016160.44039.6101100.09.7
C61Prostate553970.91629.155100.05.3
C64Kidney725069.42230.672100.03.8
C67Urinary bladder36622260.714439.3366100.09.1
C70-72Brain & nervous system41335786.45613.6413100.03.0
C73Thyroid481225.03675.048100.020.3
C82-85+C96Non-Hodgkin lymphoma31225983.05317.0312100.04.8
C90Multiple myeloma13711886.11913.9137100.03.3
C91Lymphoid leukaemia817086.41113.681100.02.4
C92-94Myeloid leukaemia21619791.2198.8216100.02.4
C95Leukaemia unspecified1079992.587.5107100.03.6


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table5: Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1991 and 1992-2000 (Qidong, China)
- Table6b: Number of cases by cancer site and calendar period (Qidong, China, 1977-2000)
- Table7: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Qidong, China, 1977-2000 cases followed-up until 2000)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)